MAE(SZ:002009) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-11-01 00:38Group 1: Capital Market Developments - The China Securities Regulatory Commission (CSRC) emphasizes the need to enhance the inclusiveness and adaptability of the capital market during the "14th Five-Year Plan" period [1] - Key tasks include actively developing direct financing through equity and bonds, fostering high-quality listed companies, and creating a more attractive long-term investment environment [2][3] - The CSRC aims to improve the scientific and effective nature of capital market regulation and steadily expand high-level institutional openness [2] Group 2: Fund Performance Benchmark Guidelines - The CSRC has released a draft guideline for public offering securities investment fund performance benchmarks, seeking public feedback [3] - The guidelines require that performance benchmarks reflect product positioning and investment style, and that fund managers appoint experienced fund managers based on these benchmarks [5] - A decision-making mechanism for benchmark selection will be established, with company management responsible for the representativeness and sustainability of the selected benchmarks [5] Group 3: Company News - Weigao Blood Products announced plans to acquire 100% equity of Weigao Puri, constituting a major asset restructuring, with shares set to resume trading on November 3 [8] - Weigao Puri, established in 2018 with a registered capital of 106 million, specializes in pre-filled syringes and other medical packaging, supporting the localization of critical pharmaceutical materials [10] - Tianqi Co., Ltd. signed a strategic cooperation agreement with Foxconn to promote the application of intelligent robots in industrial settings, aiming to deploy at least 2,000 robots within five years [8]